Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Succinyl phosphonate trisodium salt
Cat. No.:
0225LY-1421
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Succinyl phosphonate trisodium salt serves as a pharmacological inhibitor of the enzyme alpha-ketoglutarate dehydrogenase (KGDHC).
Synonym:
864167-45-3; Succinyl phosphonate (trisodium salt); Trisodium;4-oxo-4-phosphonatobutanoate; Sodium 4-(disodiooxyphosphoryl)-4-oxobutanoate
CAS No.:
864167-45-3
Compound CID:
138911342
Formula:
C4H4Na3O6P
Formula Weight:
248.01
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Succinyl phosphonate trisodium salt can be used in metabolic studies to explore the specific inhibition of the alpha-ketoglutarate dehydrogenase complex.
Library Information
Target:
Dehydrogenase
Receptor:
α-ketoglutarate dehydrogenase
Pathways:
Metabolism; Immunology/Inflammation; NF-κB
Plate Number:
AOCL-19
Plate Location:
c4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM Water
Water Max Solubility:
125 mg/mL; 504.01 mM
